Leukotriene b4 antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 311/66 (2006.01) A61K 31/19 (2006.01) A61K 31/195 (2006.01) A61K 31/215 (2006.01) A61K 31/35 (2006.01) A61K 31/40 (2006.01) A61K 31/445 (2006.01) C07C 235/60 (2006.01) C07D 295/192 (2006.01) C07D 311/58 (2006.01) C07D 405/12 (2006.01)

Patent

CA 2081766

This invention relates to compounds of formula (I) and the stereoisomers and pharmaceutically acceptable salts thereof, wherein R is alkyl, alkenyl, alkynyl, or cycloalkylalkyl; R1 is alkyl; R2 is hydrogen or alkyl; R6 is alkyl; n is 1 to 5; p is 0 to 6; x is 0 or 2; and R4 and R5 are independently hydrogen or alkyl or together with N form a cycloalkylamine. The compounds of formula (I) are leukotriene B4 antagonists and are useful as anti- inflammatory agents and in treating disease conditions mediated by LTB4.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Leukotriene b4 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Leukotriene b4 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Leukotriene b4 antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1510734

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.